Once versus twice daily budesonide metered-dose inhaler in children with mild to moderate asthma: Effect on symptoms and bronchial responsiveness

Allergologia et Immunopathologia

Volumn 35, Issue 1, 2007, Pages 25-31

  Mallol, Javier ^a,b   Aguirre, V ^a  

^a UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^b NONE   (Chile)

Author keywords

Asthma in children; Budesonide once daily; Inhaled corticosteroids; Wheezing

Indexed keywords

BUDESONIDE; HYDROCORTISONE; METHACHOLINE;

ADOLESCENT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PATIENT COMPLIANCE; SCHOOL CHILD; SINGLE BLIND PROCEDURE; SPIROMETRY; SYMPTOM; TREATMENT RESPONSE;

EID: 34047208266     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1157/13099092     Document Type: Article

References (23)

1. Becker A, Berube D, Chad Z, Dolovich M, Ducharme F, et al. Canadian Network For Asthma Care; Canadian Thoracic Society. Canadian Pediatric Asthma Consensus guidelines, 2003 (updated to December 2004): introduction. CMAJ. 2005;173: S12-4.
2. Szefler S, Pedersen S. Role of budesonide as maintenance therapy for children with asthma. Pediatr Pulmonol. 2003;36: 13-21.
3. Jónasson G, Carlsen K-H, Mowinckel P. Asthma drug adherence in a long term clinical trial. Arch Dis Child 2000;83:330-3.
4. Bauman LJ, Wright E, Leickly FE, Crain E, Kruszon-Moran D, Wade SL, Visness CM. Relationship of adherence to pediatric asthma morbidity among inner-city children. Pediatrics. 2002;110:e6.
5. Bender B, Wamboldt FS, O'Connor SL, Rand C, Szefler S, Milgrom H, Wamboldt MZ. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol. 2000; 85:416-21.
6. Möller C, Strömberg L, Oldaeus G, Arweström, Kjellman M. Efficay of once-daily versus twice-daily administration of budesonide by Turbuhaler in children with stable asthma. Pediatr Pulmonol. 1999;28:337-43.
7. Herjavecz I, Blomqvist P, Serrano A. Efficacy of once- and twice-daily administration of budesonide via Turbuhaler as initial therapy in patients with mild persistent asthma. Respir Med. 1999;93:230-5.
8. Jones AH, Langdon CG, Lee PS, Lingham SA, Nankani JP, Follows RM, Tollemar U, Richardson PD. Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma. Respir Med. 1994;88:293-9.
9. Selroos O, Edsbacker S, Hultquist C. Once-daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation. J Asthma. 2004;41:771-90.
10. Weiner P, Weiner M, Azgad Y. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma. Thorax. 1995;50:1270-3.
11. Sheffer AL, Silverman M, Woolcock AJ, Diaz PV, Lindberg B, Lindmark B. Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study. Ann Allergy Asthma Immunol. 2005;94:48-54.
12. Masoli M, Weatherall M, Holt S, Beasley R. Budesonide once versus twice-daily administration: meta-analysis. Respirology. 2004;9:528-34.
13. Miller M.R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten C.P.M, Gustafsson P, Jensen R, Johnson D.C, MacIntyre N, McKay R, Navajas D, Pedersen O.F, Pellegrino R, Viegi G. and Wanger J. Standardisation of spirometry Eur Respir J. 2005;26:319-38.
14. Knudson RJ, Slatin RC, Lewobitz MD, Burrows B. The maximal expiratory flow-volume curve: Normal standards, variability, and effects of age. Am Rev Respir Dis. 1976;113:587-600.
15. Cockcroft DW, Killlian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977;235-43.
16. Mallol J, Aguirre V, Rhen R, Rodríguez J, Dolovich M. Therapeutic equivalence of 3 metered-dose inhalers containing salbutamol in protecting against methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol. 2001;32:447-52.
17. Yates DH, Worsdell M, Barnes PJ. Effect of Regular Salmeterol Treatment on Albuterol-induced Bronchoprotection in Mild Asthma. Am. J. Respir. Crit. Care Med 1997;156:988-991.
18. Shapiro GG, Mendelson LM, Pearlman DS. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids. Ann Allergy Asthma Immunol. 2001;86:633-40.
19. DeMore M, Adams C, Wilson N, Hogan MB. Parenting Stress, Difficult Child Behavior, and Use of Routines in Relation to Adherence in Pediatric Asthma. Children's Health Care. 2005;34: 245-59.
20. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. New Engl J Med. 2000;343:1054-63.
21. Obase Y, Shimoda T, Kawano T, Saeki S, Tomari S, Izaki K, Fukushima C, Matsuse H, Kohno S. Bronchial hyperresponsiveness and airway inflammation in adolescents with asymptomatic childhood asthma. Allergy. 2003;58:213-20.
22. Van Grunsven PM, Van Schayck CP, Molema J, Akkermans RP, Van Weel C. Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis. Thorax. 1999;54:316-22.
23. Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O'Byrne PM, Lofdahl CG, Pauwels RA, Ullman A. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med. 1999;160:594-99